MASSACHUSETTS FINANCIAL SERVICES CO /MA/
Position in BMY — Bristol Myers Squibb Co
CIK 912938
Boston, MA
Position in BMY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$54,648,359
-$9,083,568 QoQ
Shares Held
948,427
-9.7% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#159
of 2,514 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 69%
Shared 16%
None 15%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $6,486,971,678 across 12 Drug Manufacturers - General names. BMY ranks #7 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,539,098 | $2,676,614,716 | |
| 2 | PFE |
Pfizer Inc
|
56,551,011 | $1,361,748,341 | |
| 3 | ABBV |
AbbVie Inc.
|
4,388,338 | $1,104,281,370 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
6,651,833 | $840,392,576 | |
| 5 | LLY |
ELI LILLY & Co
|
145,790 | $174,864,912 | |
| 6 | BIIB |
Biogen Inc.
|
744,892 | $160,941,363 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
948,427 | $54,648,359 | |
| 8 | NVS |
Novartis AG
|
293,443 | $45,988,386 |
All Filings in BMY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $54,648,359 | 948,427 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $63,731,927 | 1,050,815 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $41,428,075 | 768,040 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $3,701,762 | 82,079 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $3,652,048 | 78,895 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,298,284 | 37,683 | Shares | Sole | 2025-05-02 | |
| 2023-06-30 | $224,784 | 3,515 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,273,571 | 18,375 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,207,608 | 16,784 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $293,104 | 4,123 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $340,956 | 4,428 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $294,749 | 4,036 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $2,653,802 | 42,563 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,494,606 | 42,160 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $439,475 | 6,577 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $875,296 | 13,865 | Shares | Sole | 2021-05-13 | |
| 2020-09-30 | $24,716,065 | 409,953 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $35,435,348 | 602,642 | Shares | Sole | 2020-11-20 | |
| 2020-03-31 | $48,094,755 | 862,841 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||